Blood viscosity of COVID-19 patient: a preliminary report
- PMID: 33796395
- PMCID: PMC8010604
Blood viscosity of COVID-19 patient: a preliminary report
Abstract
COVID-19 is the important global problem. This new coronavirus can cause several hematological changes. Thrombosis is a problem might occur in COVID-19. In COVID-19, thrombosis might be the result of endothelial dysfunction, platelet activation, increasd blood viscosity, and blood flow disturbance. The change of blood viscosity in the patients with COVID-19 is possible but little mentioned. Here, the authors report on a preliminary data on blood viscosity assessment among 41 COVID-19 patients. According to the estimation, the estimated blood viscosity values are 72.4 ± 18.6 and 18.2 ± 2.2 for high and low shear rates. Based on this preliminary report, the increased blood viscosity is detected in COVID-19 patient and it might be associated with thrombohemostatic problem.
Keywords: COVID-19; blood; viscosity.
AJBR Copyright © 2021.
Conflict of interest statement
None.
Figures
References
-
- Vieira JM, Ricardo OMP, Hannas CM, Kanadani TCM, Prata TDS, Kanadani FN. What do we know about COVID-19? A review article. Rev Assoc Med Bras (1992) 2020;66:534–540. - PubMed
-
- Tin SS, Wiwanitkit V. Uncommon atypical presentations of COVID-19: important and should not be under recognized! J Health Sci Med Res. 2020;38:153–158.
LinkOut - more resources
Full Text Sources